OTCMKTS:YBGJ Yubo International Biotech (YBGJ) Stock Price, News & Analysis $0.04 +0.00 (+10.97%) As of 08/28/2025 10:12 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsShort InterestBuy This Stock About Yubo International Biotech Stock (OTCMKTS:YBGJ) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get YBGJ alerts:Sign Up Key Stats Today's Range$0.03▼$0.0450-Day Range$0.02▼$0.1452-Week Range$0.02▼$0.54Volume40,000 shsAverage Volume125,881 shsMarket Capitalization$6.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China. Read More Receive YBGJ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yubo International Biotech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. YBGJ Stock News HeadlinesYubo International Biotech Limited (YBGJ)March 21, 2025 | finance.yahoo.comYubo International Biotech LimitedNovember 21, 2024 | investing.comMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.August 29 at 2:00 AM | The Oxford Club (Ad)YBGJ Yubo International Biotech LimitedMay 24, 2024 | seekingalpha.comPromontory Therapeutics Selected as the First International Biotech Company Member of the Paris-Saclay Cancer ClusterOctober 1, 2023 | finance.yahoo.comYubo International Biotech Ltd.June 15, 2023 | wsj.comYubo International (OTC:YBGJ), Earnings Estimates, EPS, and RevenueJuly 18, 2022 | benzinga.comYubo International (OTC:YBGJ), Analyst Ratings, Price Targets, PredictionsJuly 18, 2022 | benzinga.comSee More Headlines YBGJ Stock Analysis - Frequently Asked Questions How have YBGJ shares performed this year? Yubo International Biotech's stock was trading at $0.0347 at the beginning of 2025. Since then, YBGJ shares have increased by 2.0% and is now trading at $0.0354. How do I buy shares of Yubo International Biotech? Shares of YBGJ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Yubo International Biotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Yubo International Biotech investors own include AutoZone (AZO), Intel (INTC), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM), Bank of America (BAC) and Cal-Maine Foods (CALM). Company Calendar Today8/29/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolOTCMKTS:YBGJ CIK895464 Webwww.yubogroup.com Phone(640) 677-6010Fax516-595-1159Employees20Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.77 million Net MarginsN/A Pretax Margin-57,118.15% Return on EquityN/A Return on Assets-118.36% Debt Debt-to-Equity RatioN/A Current Ratio0.13 Quick Ratio0.12 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / Book-1.77Miscellaneous Outstanding Shares170,420,000Free Float53,683,000Market Cap$6.03 million OptionableNot Optionable Beta3.74 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:YBGJ) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yubo International Biotech Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Yubo International Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.